Author: Emma Mueller

by
Clinical Trials
September 17, 2026

Sponsored by Anagram Therapeutics Anagram Therapeutics, Inc is developing a non-porcine Pancreatic Enzyme Replacement Therapy (PERT)- ANG003.  For people with Cystic Fibrosis (PwCF) with exocrine pancreatic insufficiency (EPI), the currently approved PERTs are porcine (pig) derived and require enteric (plastic) coating to allow the capsules to...

by
Blog
July 1, 2026

by Rosie Garvey Food insecurity is a pressing issue that affects people across the United States, in rural and urban communities alike. According to the most recent national data, in 2024, 13.4% of households in the US experienced food insecurity. This means that at some point...

by
Clinical Trials
October 2, 2025

Post sponsored by Clarametyx While new therapies for cystic fibrosis (CF) are increasingly available to our community, many people with CF still face persistent and repeated infections that require the use of antibiotics. Now, researchers are developing a new approach to address these chronic infections by...